Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 11,403,766 $ 864,840
Prepaid expenses and other current assets 1,301,778 607,670
Total current assets 12,705,544 1,472,510
Total assets 12,705,544 1,472,510
Current liabilities:    
Accounts payable and accrued expenses 2,479,272 1,355,867
Short-term notes payable, net of debt issuance costs 394,836 328,528
Total liabilities 2,874,108 1,684,395
Stockholders’ equity (deficit):    
Preferred stock, no par value; 50,000,000 shares authorized; 432,122 Series H and 7,488,692 Series F outstanding at September 30, 2025, and 0 Series H and 7,488,692 Series F outstanding at December 31, 2024.
Common stock, $0.001 par value; 350,000,000 shares authorized; 4,127,173 and 419,003 shares issued and outstanding at September 30, 2025, and December 31, 2024, respectively 4,127 419
Additional paid-in capital 234,169,098 216,573,868
Accumulated deficit (224,341,789) (216,786,172)
Total stockholders’ equity (deficit) 9,831,436 (211,885)
Total liabilities and stockholders’ equity (deficit) $ 12,705,544 $ 1,472,510